论文部分内容阅读
虽然血小板被认为与脑血管病及冠心病发病机理有重要关系。但并非全部暂时性脑缺血发作(TIA)与心肌梗塞(MI)之猝死均来自新的血栓佺塞的后果。抗血小板药物有不同药理作用,因而在不同临床情况下其效力也不尽相同,且导致TIA患者中风的血栓栓塞意外,其发病机理可能也与冠心病者的复发梗塞或死亡不同。故药物对一种病有效对其他种不一定有
Although platelets are thought to play an important role in the pathogenesis of cerebrovascular disease and coronary heart disease. However, not all sudden deaths from transient ischemic attacks (TIA) and myocardial infarction (MI) result from the consequences of a new thromboembolism. Anti-platelet drugs have different pharmacological effects, which in different clinical situations its effectiveness is not the same, and lead to stroke in patients with TIA thromboembolic accident, its pathogenesis may also be different with coronary heart disease, recurrent infarction or death. Therefore, the effective medicine for one kind of disease does not necessarily have to others